Organisation The European Committee on Antimicrobial Susceptibility Testing (EUCAST) is mandated by ESCMID, EMA, ECDC, EFSA and partners across Europe to define, harmonize and standardize antimicrobial breakpoints and testing methods. EUCAST structure and procedures have been developed with ESCMID,…
Get to know moreFollowing public consultation, EUCAST publishes formal responses to queries and views submitted during the consultation period. The comments during the consultation on EUCAST proposed endocarditis breakpoints , the EUCAST responses and decisions are now published (20 November, 2024). Throughout the…
Get to know moreEUCAST public consultation on breakpoints for intravenous use of fosfomycin . Consultation period 12 July - 12 September, 2023. The proposal has been revised following comments to the previous consultation and discussions with the EUCAST Steering Committee and stakeholders. Do not iterate comments…
Get to know moreMIC and zone diameter data on temocillin added to the Enterobacterales calibration/validation file (28 February, 2022). For anyone using EUCAST disk diffusion AST criteria, the calibration/validation files will provide valuable information and allow laboratories to benchmark local efforts with files…
Get to know moreEUCAST is considering removing breakpoints for piperacillin without tazobactam and/or ticarcillin without clavulanic acid but only if these agents are no longer used. If you in your country are still using either or both of these agents without an inhibitor, please inform the EUCAST Scientific…
Get to know moreEUCAST will during 2023, based on the work of theEMERGE AST Working Group , strive to publish clinical breakpoints and disk diffusion correlates for Brucella melitensis and Bacillus anthracis. Through the joint effort of the group and EUCAST, MIC and zone diameter distributions are now available .…
Get to know moreSubcommittee on Antimycobacterial Susceptibility Testing (AMST) In November 2014, a workshop in Basel brought together representatives from the EUCAST Steering Committee, the ESCMID Study Group for Mycobacterial Infections (ESGMYC), and the European Medicines Agency (EMA) to discuss data…
Get to know moreEducation Stay informed on EUCASTs upcoming and previous educational activities here. If you have any feedback or ideas, please contact us via the contact form in the bottom of the page. Upcoming Activites Upcoming activites (e.g. webinars) will be announced here. Previous Activities Previous…
Get to know moreThe correlation between MIC and inhibition zone diameters in disk diffusion is excellent when utilizing species specific breakpoints for anaerobic species and species groups, in the same way EUCAST has dealt with facultative aerobic bacteria over the last 25 years. In this presentation the EUCAST…
Get to know moreThere is a mistake in the EUCAST breakpoint table v 11.0 where, in the Staphylococcus spp tab, the fluroquinolone section, the footnote C should read:Isolates categorised as susceptible to norfloxacin can be reported susceptible (S) to moxifloxacin and "susceptible increased exposure" (I) to…
Get to know more
We’ve prepared a short video to help you get familiar with the new layout and features.